Bridging the Gap between R&D and Manufacturing
Hear from Emergent's development services technical experts as they discuss several key parameters that can lead to the successful and seamless scale up of a drug development program for clinical and commercial GMP manufacturing.
This presentation includes:
- Insights and perspectives from Emergent's experienced analytical, drug substance, and drug product development teams
- An overview of Emergent's comprehensive development services offering
- Q&A session
ORIGINALLY PRESENTED ON JULY 27, 2021